Trial ID 20289 EDP Rockville | Maryland Oncology Hematology

Trial ID 20289 EDP Rockville

Trial Information - Phase I

A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies

Disease Specifics: (cutanous)

Protocol ID: SGNTGT-001

Sponsor: Seagen, Inc.

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Melanoma

Investigator

Wallmark MD, John

Status

OPEN TO ENROLLMENT

Sponsor

Seagen, Inc.

« Clinical Trails Main

Quality Care Close to Home

View our locations on map!